EMEA-001389-PIP01-12

Key facts

Active substance
Deleobuvir
Therapeutic area
Infectious diseases
Decision number
P/0240/2013
PIP number
EMEA-001389-PIP01-12
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
Condition(s) / indication(s)
Treatment of chronic viral hepatitis C
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH

Tel. +49 6132 778271
Email: Paediatrics@boehringer-ingelheim.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating